- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: statins, ezetimibe, bempedoic acid, evolocumab, alirocumab, inclisiran
Total 36 results
-
Jena University HospitalNot yet recruitingST Elevation Myocardial Infarction | Non-ST Elevation Myocardial Infarction | LDL-cholesterolGermany
-
University Clinical Centre of Republic of SrpskaRecruitingDyslipidemias | Acute Coronary SyndromeBosnia and Herzegovina
-
University of SalernoNot yet recruitingCardiovascular Diseases | Dyslipidemias | Lipid Metabolism Disorders | Statin Adverse Reaction
-
Esperion Therapeutics, Inc.Recruiting
-
Esperion Therapeutics, Inc.Completed
-
Federico II UniversityRecruitingHypercholesterolemiaItaly
-
Esperion Therapeutics, Inc.Completed
-
Esperion Therapeutics, Inc.CompletedHypercholesterolemiaUnited States
-
Novartis PharmaceuticalsCompletedAtherosclerotic Cardiovascular DiseaseFrance
-
SanofiRegeneron PharmaceuticalsCompletedHypercholesterolaemiaNorway, Russian Federation, Sweden, South Africa, Czechia, United States, Canada, France, Netherlands, Spain
-
Esperion Therapeutics, Inc.CompletedDiabetes Mellitus, Type 2 | Diabetes | CholesterolemiaUnited States
-
NYU Langone HealthCompleted
-
Kaiser PermanenteEsperion Therapeutics, Inc.Not yet recruitingCardiovascular Diseases | STEMI | NSTEMIUnited States
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingHypercholesterolemia | Mixed DyslipidemiaAustria, United Kingdom, Italy, Germany, Belgium
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyWithdrawnMixed Dyslipidemia | Primary Hypercholesterolemia
-
SanofiRegeneron PharmaceuticalsCompletedDyslipidemiaUnited States, Australia, Brazil, Finland, Germany, Israel, Italy, Kuwait, Lebanon, Norway, Sweden, Switzerland, Turkey, United Arab Emirates, United Kingdom
-
Xuanwu Hospital, BeijingNot yet recruitingAcute Ischemic Stroke
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyDaiichi Sankyo GermanyCompleted
-
CHU de Quebec-Universite LavalCanadian Institutes of Health Research (CIHR); BiovaloremActive, not recruitingPancreatic Cancer | Metastatic Cancer | Pancreatic Ductal Adenocarcinoma | Pancreas CancerCanada
-
University of LouisvilleRecruitingCoronary Artery Disease | Atherosclerosis | Heart AttackUnited States
-
Icahn School of Medicine at Mount SinaiCompletedCoronary Artery DiseaseUnited States
-
Esperion Therapeutics, Inc.Completed
-
Esperion Therapeutics, Inc.CompletedAtherosclerosis | Hypercholesterolemia | Statin Adverse ReactionUnited States
-
Beijing Anzhen HospitalBeijing Municipal Health CommissionRecruiting
-
Wuhan Union Hospital, ChinaRecruitingHigh-Resolution Assessment of Extracranial Plaques in a Multiple Centers Evolocumab Randomized StudyCerebral AtherosclerosisChina
-
Yonsei UniversityDaewoong Pharmaceutical Co. LTD.RecruitingLow-Density-Lipoprotein-Type [LDL] HyperlipoproteinemiaKorea, Republic of
-
Food and Drug Administration (FDA)Spaulding Clinical Research LLCCompletedHealthy Subjects | Pharmacokinetics | PharmacodynamicsUnited States
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)Recruiting
-
GWT-TUD GmbHActive, not recruitingDyslipoproteinemiasGermany
-
Brigham and Women's HospitalAmgenRecruiting
-
Xiang XieXinjiang Medical UniversityNot yet recruitingCancer | Atherosclerotic Cardiovascular Disease | ASCVD | Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor
-
Lin ZhaoRecruitingIn-stent Restenosis | Major Adverse Cardiovascular EventsChina
-
SanofiRegeneron PharmaceuticalsCompletedHypercholesterolemiaSlovenia, Taiwan, Russian Federation, Canada, Netherlands, Brazil, Denmark, Mexico, Spain, Turkey
-
SanofiRegeneron PharmaceuticalsCompletedHypercholesterolaemiaCzechia, France, Denmark, Netherlands, Austria, Mexico, Spain, United States, Argentina, Brazil, Bulgaria, Canada, Finland, Hungary, Italy, Lebanon, Norway, Poland, Russian Federation, Slovenia, South Africa, Sweden, Taiwan, Turkey
-
Tongji HospitalRecruitingIschemic Stroke | Large-Artery Atherosclerosis (Embolus/Thrombosis)China
-
Baylor College of MedicineNational Heart, Lung, and Blood Institute (NHLBI)CompletedPeripheral Arterial DiseaseUnited States